Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study

被引：0
|
作者：
Orlandi-Jorquera, L
Orlandi, F
Galaz, P
Gamargo, C
Salman, P
Yanez, M
机构：
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
486
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [31] A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life
    Jassem, J
    Krzakowski, M
    Roszkowski, K
    Ramlau, R
    Slominski, JM
    Szczesna, A
    Krawczyk, K
    Mozejko-Pastewka, B
    Lis, J
    Miracki, K
    LUNG CANCER, 2002, 35 (01) : 73 - 79
  • [32] Elderly patients with advanced non-small cell lung cancer - A phase II study with weekly cisplatin and gemcitabine
    Berardi, R
    Porfiri, E
    Scartozzi, M
    Lippe, P
    Silva, RR
    Nacciarriti, D
    Menichetti, ET
    Tummarello, D
    Carle, F
    Piga, A
    Cellerino, R
    ONCOLOGY, 2003, 65 (03) : 198 - 203
  • [33] Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study
    S Niho
    K Kubota
    K Goto
    H Ohmatsu
    T Matsumoto
    R Kakinuma
    Yutaka Nishiwaki
    British Journal of Cancer, 2002, 87 : 1360 - 1364
  • [34] Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling
    Huisman, C
    Giaccone, G
    van Groeningen, CJ
    Sutedja, G
    Postmus, PE
    Smit, EF
    LUNG CANCER, 2001, 33 (2-3) : 267 - 275
  • [35] Randomized phase III study of Gemcitabine/cisplatin versus mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer (NSCLC)
    Scagliotti, G
    Crino, L
    Conte, PF
    Rinaldi, M
    De Marinis, F
    Gridelli, C
    ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
  • [36] Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study
    Niho, S
    Kubota, K
    Goto, K
    Ohmatsu, H
    Matsumoto, T
    Kakinuma, R
    Nishiwaki, Y
    BRITISH JOURNAL OF CANCER, 2002, 87 (12) : 1360 - 1364
  • [37] A phase II of gemcitabine in advanced non-small cell lung cancer
    Koynov, K
    Tzekova, V
    Mincheva, N
    Scherer, A
    Krejcy, K
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 231 - 234
  • [38] Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer
    Mok, TSK
    Lam, KC
    Lee, C
    Zhang, L
    Wong, H
    Chan, ATC
    Yeo, W
    Yim, APC
    Chak, K
    Zee, B
    ONCOLOGY, 2005, 68 (4-6) : 485 - 492
  • [39] Phase II study with high-dose gemcitabine (GEM) plus cisplatin (CDDP) in advanced non-small-cell lung cancer (NSCLC).
    Tres, A
    Isla, D
    Mayordomo, JI
    Escudero, P
    Sáenz, A
    Bueso, P
    Herráez, J
    Marti, JL
    Murillo, L
    Filipovich, E
    ANNALS OF ONCOLOGY, 2000, 11 : 109 - 109
  • [40] Phase II study of weekly gemcitabine in advanced non-small cell lung cancer
    Halme, M
    Jekunen, A
    Tamminen, K
    Mattson, K
    RESPIRATORY MEDICINE, 1997, 91 (07) : 423 - 426
12345